Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Qiou Gu"'
Autor:
QIOU GU1, CHUILIN LAI1, XIAO GUAN1, JING ZHU2, TIAN ZHAN1, JIANPING ZHANG1 drzhangjp@njmu.edu.cn
Publikováno v:
Biocell. 2024, Vol. 48 Issue 2, p253-269. 17p.
Autor:
Qiou Gu, Lei Mi, Chuilin Lai, Xiao Guan, Na Lu, Tian Zhan, Guoguang Wang, Chen Lu, Lei Xu, Xiang Gao, Jianping Zhang
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e21909- (2024)
Background: Gastric cancer (GC) is the fourth most common cause of cancer-related death and the fifth most frequent malignant cancer, especially advanced GC. Carboxypeptidase X member 1 (CPXM1) is an epigenetic factor involved in many physiological p
Externí odkaz:
https://doaj.org/article/ca328863f73b463b922b6c0f159512a3
Autor:
Wen Peng, Jie Li, Ranran Chen, Qiou Gu, Peng Yang, Wenwei Qian, Dongjian Ji, Qingyuan Wang, Zhiyuan Zhang, Junwei Tang, Yueming Sun
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-16 (2019)
Abstract Background m6A modification has been proved to play an important role in many biological processes. METTL3 as the main methyltransferase for methylation process has been found to be upregulated in many cancers, including CRC. Here, we invest
Externí odkaz:
https://doaj.org/article/739eab4131b4484fb437a9965acb14d3
Autor:
Yifei Feng, Wenwei Qian, Yue Zhang, Wen Peng, Jie Li, Qiou Gu, Dongjian Ji, Zhiyuan Zhang, Qingyuan Wang, Dongsheng Zhang, Yueming Sun
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Cell division cycle associated 2 (CDCA2), upregulated in lung adenocarcinoma and oral squamous cell carcinoma, may be related to some malignant diseases. Nevertheless, its role in colorectal cancer (CRC) remains unknown. Methods C
Externí odkaz:
https://doaj.org/article/b5b17a591c8f42fba7d49f95d112f5d9
Autor:
QIOU GU, TIAN ZHAN, XIAO GUAN, CHUILIN LAI, NA LU, GUOGUANG WANG, LEI XU, XIANG GAO, JIANPING ZHANG
Publikováno v:
Oncology Research. 31:287-297
Autor:
Peng Yang, Jie Li, Chaofan Peng, Yuqian Tan, Ranran Chen, Wen Peng, Qiou Gu, Jiahui Zhou, Lu Wang, Junwei Tang, Yifei Feng, Yueming Sun
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 6, Pp n/a-n/a (2020)
Abstract Background Long noncoding RNAs (lncRNAs) have emerged as key regulators in multiple cancers, including colorectal cancer (CRC). However, the biological functions and molecular mechanisms underlying most lncRNAs in CRC remain largely unknown.
Externí odkaz:
https://doaj.org/article/bd83ee5d18cb4749832c94a5061095df
Autor:
Jie Li, Wen Peng, Peng Yang, Ranran Chen, Qiou Gu, Wenwei Qian, Dongjian Ji, Qingyuan Wang, Zhiyuan Zhang, Junwei Tang, Yueming Sun
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
MicroRNAs (miRNAs) are small non-coding RNAs that play pivotal roles in cancer initiation and progression. However, the roles and molecular mechanisms of miRNAs in colorectal cancer (CRC) progression remain unclear. Here, we show that downregulation
Externí odkaz:
https://doaj.org/article/2389d9fd03804b758f7505e7f67788e5
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
MicroRNAs (miRNAs) are non-coding small RNA molecules that regulate gene expression at the post-transcriptional/translational level. They act a considerable role not only in the normal progress of development but also in aberrant human diseases, incl
Externí odkaz:
https://doaj.org/article/8e24c2fe77104027ace9ba035249e6bc
Background With the popularity of function-preserving gastrectomy(FPG) and minimally invasive surgery, proximal gastrectomy(PG) has been widely used in the upper third gastric cancer. There are many reconstruction methods after PG, but the optimal on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecc3bfaf41cbbb060a1ca25fb8a8fe40
https://doi.org/10.21203/rs.3.rs-2392046/v1
https://doi.org/10.21203/rs.3.rs-2392046/v1
Autor:
Chaofan Peng, Yuqian Tan, Peng Yang, Yueming Sun, Yuanjian Huang, Lu Wang, Qing Zhang, Yuchen Sheng, Qiou Gu, Yan Wang, Guoqiang Shao, Ranran Chen, Wen Peng, Jiahui Zhou, Jie Li
Publikováno v:
Biomaterials Science. 9:2279-2294
Antibody-functionalized targeted nanocarriers to deliver chemotherapeutics have been widely explored. However, it remains highly desirable to understand and apply the antitumor potential of antibodies integrated in hybrid composite nanoplatforms. Her